Summary
Andrey Chursov is a founder and CEO leading Datomics Group, a stealth Silicon Valley AI biotech focused on turning cancer into a nonfatal disease, with eight years of industry experience bridging computational biology and software engineering. He combines a PhD-level background in bioinformatics with MIPT training in machine learning and data science to build and scale teams and platforms that translate ML research into therapeutic insights. Previously he led engineering and data at PACT Pharma and held senior bioinformatics roles at Guardant Health and Memorial Sloan Kettering, giving him deep domain expertise across cancer genomics, diagnostics, and drug discovery. Andrey has a track record of founding and advising startups, serves as a limited partner at AAL VC, and has held senior science and technology leadership at Zephyr AI—demonstrating both entrepreneurial grit and investment acumen. A Kaggle Expert who describes himself as a “Warrior of the Light,” he blends hands-on data science chops with strategic product leadership to drive high-impact translational research.
8 years of coding experience
11 years of employment as a software developer
Ph.D., Bioinformatics and Computational Biology, Ph.D., Bioinformatics and Computational Biology at Technical University of Munich
M.Sc., Machine Learning/Computer Science, M.Sc., Machine Learning/Computer Science at Moscow Institute of Physics and Technology (State University) (MIPT)
M.Sc., Data Science, M.Sc., Data Science at Yandex School of Data Analysis
English, Russian